China Biologic Opens New Plasma Collection Station As China’s Blood Product Reforms Have Closed Doors For Many Competitors
This article was originally published in PharmAsia News
Executive Summary
SHANGHAI - China Biologic Products began operations at its new plasma collection station in Qihe County, Shandong Province, the company announced July 9, increasing its annual supply of plasma from 60 to 80 metric tons to 100 metric tons
You may also be interested in...
China Blood Products Market Increases Steadily, Driven By Increased Price And Government's Stricter Supervision
SHANGHAI - The sale of blood products in China reached $3.966 billion in 2008 with an annual growth rate 12.23 percent, according to consulting company Draco Healthcare. The growth will continue in the future, driven by increasing demand, limited supply and higher prices
China Blood Products Market Increases Steadily, Driven By Increased Price And Government's Stricter Supervision
SHANGHAI - The sale of blood products in China reached $3.966 billion in 2008 with an annual growth rate 12.23 percent, according to consulting company Draco Healthcare. The growth will continue in the future, driven by increasing demand, limited supply and higher prices
China Biologic Renews GMP Certification Under Stiffer SFDA GMP Rules
SHANGHAI- China Biologic Products has renewed its GMP certification for its production facility in Taian City in compliance with China State FDA's new, strict GMP standards, which took effect in January